LIGAND PHARMACEUTICALS INCORPORATED

Company

LIGAND PHARMACEUTICALS INC

Filed

March 10, 2006

Accession Number

0000902664-06-001003

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →